Cord blood banking is the process of collecting and storing blood from a newborn’s umbilical cord immediately after birth. This blood is rich in a specific type of stem cell that can rebuild the blood and immune system, making it valuable for treating cancers like leukemia and lymphoma, inherited immune deficiencies, and certain metabolic disorders. Parents can choose to donate cord blood to a public bank for anyone who needs it or pay to store it privately for their own family’s potential future use.
Why Cord Blood Is Medically Valuable
The blood left in the umbilical cord and placenta after delivery contains a high concentration of stem cells that produce all the different types of blood cells: red cells, white cells, and platelets. These are the same kind of stem cells found in bone marrow, but cord blood versions are biologically younger and more potent. They carry two to three times more surface markers that identify them as stem cells compared to adult bone marrow cells, and they divide and multiply faster in laboratory settings.
The reason comes down to cellular age. Cord blood stem cells have significantly longer telomeres, the protective caps on the ends of chromosomes that shorten each time a cell divides. Longer telomeres mean these cells can replicate more times before wearing out. They also exit their resting phase more quickly, which translates to faster growth and a greater capacity for self-renewal. In animal studies, cord blood stem cells outperform adult bone marrow cells at rebuilding a functioning blood system from scratch.
These properties make cord blood a proven alternative to bone marrow for transplants. It’s used to treat blood cancers, sickle cell disease, thalassemia, severe combined immunodeficiency, and certain inherited metabolic conditions. For patients who need a stem cell transplant but can’t find a matched bone marrow donor, cord blood offers a viable option, partly because it doesn’t require as precise a tissue match.
How Cord Blood Is Collected
Collection happens in the minutes right after delivery, once the umbilical cord has been cut. A healthcare provider inserts a needle into the vein of the clamped cord and drains the remaining blood into a sterile collection bag. The process takes about 10 minutes, is painless for both mother and baby, and doesn’t interfere with delivery or immediate postpartum care.
One important consideration is timing. Many hospitals now practice delayed cord clamping, waiting 30 to 60 seconds or longer before cutting the cord to allow more blood to flow to the newborn. This benefits the baby, particularly in preventing iron deficiency, but it significantly reduces the amount of cord blood available for banking. Research from a public cord blood bank found that the proportion of collected units meeting screening criteria dropped from 39% with immediate clamping to just 17% when clamping was delayed by 60 seconds. If you’re planning to bank cord blood, this is worth discussing with your OB or midwife beforehand so you can weigh the tradeoffs together.
Public vs. Private Banking
The two options work very differently in terms of cost, access, and how the cord blood is actually used.
Public cord blood banks are nonprofit. You donate your baby’s cord blood at no cost, and it becomes available to any patient worldwide who needs a transplant match. Public banks are heavily regulated and subject to strict quality oversight. The donated units are typed, tested, and listed on registries that transplant centers search when looking for matches. The American Academy of Pediatrics has consistently recommended public banking over private, noting that cord blood stored in the public system is 30 times more likely to actually be used for a transplant than privately banked cord blood.
Private cord blood banks store the sample exclusively for your family. The idea is that if your child or a close relative ever needs a stem cell transplant, you’d have a perfectly matched or closely matched unit ready. Processing typically costs around $800 to $1,200 upfront, with annual storage fees running about $200 per year. Some companies offer bundled options that include storing cord tissue (the cord itself, which contains different types of stem cells) for an additional fee. Over 18 years of storage, the total cost can reach $5,000 or more.
Private banks face less regulatory oversight than public banks. The AAP has cautioned that privately stored cord blood is significantly underutilized, meaning most families who pay for storage never end up using it. The probability that a healthy child will need their own stored cord blood is very low. For many conditions that cord blood treats, using the patient’s own cells isn’t even ideal, because those cells may carry the same genetic defect that caused the disease.
When Private Banking Makes More Sense
There are specific situations where private banking becomes a more practical decision rather than a speculative one. If you already have a child or close family member with a condition treatable by stem cell transplant, storing a new sibling’s cord blood provides a potential donor match within the family. Siblings have a 25% chance of being a perfect tissue match, and cord blood transplants tolerate partial mismatches better than bone marrow does.
Families with a known history of blood cancers, inherited immune disorders, or metabolic diseases like Hurler syndrome may also benefit. In these cases, directed banking (storing the sample with a specific patient in mind) is sometimes available through public banks at no charge. It’s worth asking your doctor or a public bank coordinator whether this option applies to your family.
Limitations of Cord Blood
A single cord blood unit contains a limited number of stem cells, and this is the biggest practical constraint. The cell count is generally sufficient for transplants in children, but often falls short for adults. A larger body requires more stem cells to rebuild the blood system effectively, and a typical cord blood collection may not provide enough for timely recovery in a full-grown patient. Transplant centers sometimes address this by using two cord blood units from different donors in a single procedure, though this adds complexity.
This cell-dose limitation disproportionately affects adults and people of color, particularly African Americans, who are already underrepresented in bone marrow donor registries and face greater difficulty finding well-matched units. Expanding public cord blood donations from diverse populations remains one of the most direct ways to address this gap.
What to Look for in a Cord Blood Bank
If you choose private banking, look for accreditation from AABB (formerly the American Association of Blood Banks) or FACT (Foundation for the Accreditation of Cellular Therapy). These organizations set standards for how cord blood is collected, processed, tested, and stored. Accredited banks undergo regular inspections and must meet requirements for cell viability, sterile handling, and long-term cryopreservation.
Ask about the bank’s processing method, since different techniques recover different percentages of stem cells from the raw collection. Ask how many successful transplants have used units from that bank, and what happens to your stored sample if the company goes out of business. Some private banks have closed or been acquired over the years, and not all have clear policies for transferring samples.
For public donation, availability depends on where you deliver. Not every hospital partners with a public cord blood bank, so check early in your pregnancy. The National Marrow Donor Program maintains a list of participating hospitals. If your hospital doesn’t offer public collection, some banks accept mail-in donations, though the logistics are more limited.
Experimental Uses Under Investigation
Beyond established transplant medicine, researchers are studying whether cord blood stem cells could help with conditions outside the blood system. Clinical trials have explored infusions of a child’s own stored cord blood for autism spectrum disorder and cerebral palsy. A completed phase 1 trial at Duke University tested the safety of cord blood infusion in children with autism, though it was designed primarily to assess safety and feasibility rather than prove effectiveness. These applications remain experimental, and no cord blood therapy for neurological conditions has received regulatory approval.
Private banks often highlight this research in their marketing, and it’s fair to acknowledge the scientific interest. But decisions about banking shouldn’t rest on the possibility of treatments that don’t yet exist. The established, proven uses of cord blood are in blood and immune system transplants, and that’s the framework for evaluating whether banking makes sense for your family.